A Role for Endogenous Transforming Growth Factor β1 in Langerhans Cell Biology: The Skin of Transforming Growth Factor β1 Null Mice Is Devoid of Epidermal Langerhans Cells
暂无分享,去创建一个
[1] O. Majdic,et al. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. , 1996, Journal of immunology.
[2] M. Arsura,et al. TGFβ1 Inhibits NF-κB/Rel Activity Inducing Apoptosis of B Cells: Transcriptional Activation of IκBα , 1996 .
[3] M. Sporn,et al. Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouse , 1996, The Journal of experimental medicine.
[4] A. Kulkarni,et al. Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. , 1996, Blood.
[5] A. Farr,et al. Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (Ep‐CAM), by murine dendritic cells , 1996, European journal of immunology.
[6] A. Geiser,et al. SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-beta knockout mice. , 1995, Journal of immunology.
[7] A. Kulkarni,et al. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. , 1995, Development.
[8] D. Lo,et al. Expression of relB is required for the development of thymic medulla and dendritic cells , 1995, Nature.
[9] F. Weih,et al. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family , 1995, Cell.
[10] A. Kulkarni,et al. Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma. , 1994, Genes & development.
[11] M. Foti,et al. Modulation of cytokine expression in mouse dendritic cell clones , 1994, European journal of immunology.
[12] A. Kulkarni,et al. Immune dysregulation in TGF-beta 1-deficient mice. , 1994, Journal of immunology.
[13] A. Singer,et al. Expression of the homotypic adhesion molecule E-cadherin by immature murine thymocytes and thymic epithelial cells. , 1994, Journal of immunology.
[14] M. Sporn,et al. Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Kunz,et al. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. , 1993, Trends in biochemical sciences.
[16] M. Sporn,et al. Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Steinman,et al. Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. , 1993, Journal of cell science.
[18] L. Picker,et al. Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. , 1993, Journal of immunology.
[19] M. Sporn,et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[20] M. Sporn,et al. Transforming growth factor-beta: recent progress and new challenges , 1992, The Journal of cell biology.
[21] G. Proetzel,et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.
[22] O. Hornstein,et al. Expression of transforming growth factor type beta on human epidermal dendritic cells. , 1992, The Journal of investigative dermatology.
[23] S. Jacobsen,et al. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[24] M. Udey,et al. Inhibition of epidermal Langerhans cell function by low dose ultraviolet B radiation. Ultraviolet B radiation selectively modulates ICAM-1 (CD54) expression by murine Langerhans cells. , 1991, Journal of immunology.
[25] S. Hosier,et al. Epithelial heterogeneity in the murine thymus: a cell surface glycoprotein expressed by subcapsular and medullary epithelium. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[26] A. Singer,et al. Ia+ murine epidermal Langerhans cells are deficient in surface expression of the class I major histocompatibility complex. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Unkeless. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors , 1979, The Journal of experimental medicine.
[28] D. Kingsley,et al. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. , 1994, Genes & development.
[29] R. Steinman,et al. The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.